Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

New antiasthmatic agents claimed by Byk Gulden

March 25, 1998

Epi-2010, a novel antisense oligonucleotide for asthma

March 24, 1998

Jak-2 inhibitor indicated for control of allergic inflammation

March 24, 1998

Clinical efficacy demonstrated for rhuMAb-E25 in asthma

March 24, 1998

PPL's AAT granted orphan drug status by FDA

March 24, 1998

Preliminary clinical efficacy demonstrated for PDE III inhibitor in asthma

March 24, 1998

Phase III trial of Procysteine i.v. suspended

March 23, 1998

Mochida describes new antiasthma agent with novel profile

March 23, 1998

L-0066: a novel inhibitor of PDE IV and mediator release in vitro

March 23, 1998

Synergistic effects of montelukast and loratadine in allergic patients

March 23, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 15, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...